In an adjunctive epilepsy trial in pediatric patients (2 to 16 years), skin disorder (3%), alopecia (2%), dermatitis (2%), hypertrichosis (2%), erythematous rash (2%), eczema (1%), seborrhea (1%), and skin discoloration (1%) occurred more frequently in topiramate-treated patients compared to patients given placebo
Invert the vial and add the correct amount of solution to the syringe
Human Data In comparison with animal data, current human studies are still scarce
doi: 10.1038/s41598-018-27395-0
However, it's important to note that despite its prospects as an injectable treatment, GHK-Cu's systemic effects are only supported by animal and in vitro studies
There is limited human clinical data available, and it is not FDA-approved for use